Genomics Strategic Core Platform

该单位从一个没有所有权的位置，研究科学家充当其大部分基因组学产出的邮箱，到现在，一个装备精良的设施，具有广泛的基因组学应用能力，包括人类全基因组测序。这与单位对Covid-19大流行的贡献和应对以及冈比亚Covid-19分离株的成功测序取得了巨大的回报。直接促进国家应对这一流行病的公共卫生工作。该平台将继续为我们的西非合作伙伴发展基因组学支持，以建立当地进行测序的能力，从而实现权力下放和所有权的传播，并加强我们次区域的基因组学。我们将开发平台能力，以进行基因组学实验，数据分析和解释，本地大型基因组，并能够承担大人口类型的基因组学。该股将继续投资建立一个区域基因组学英才中心和一个西非高通量基因组学专家平台。

The unit have moved, from a position of no ownership with research scientist acting as a postbox for most of their genomics output, to now, a highly equipped facility, with the capacity for wide range of genomics application, including human whole genome sequencing. This has paid off spectacularly with unit’s contribution and response to the Covid-19 pandemic and the successful sequencing of Covid-19 isolates in The Gambia. contributing directly to the country public health response to the pandemic. The platform will continue developing genomics support to our West African partners in establishing the local capacity to perform sequencing thus achieving decentralization and spreading of ownership and strengthening genomics in our sub-region. We will develop the platform ability to perform genomics experiment, data analysis and interpretation, locally on large genomes and being able to undertake large population type genomics. The unit will continue to invest in the establishment of a regional genomic centre of excellence and a specialist high throughput genomics platform for West Africa.